Home Finance Biogen’s New Alzheimer’s Drug Meets Slow Rollout

Biogen’s New Alzheimer’s Drug Meets Slow Rollout

19
0

Biogen’s New Alzheimer’s Drug Meets Slow Rollout


Biogen’s guidance for the rest of 2021 assumes minimal revenue from Aduhelm, with an increase after that.

Photo: Adam Glanzman/Bloomberg News

Published at Wed, 20 Oct 2021 12:31:00 +0000

https://www.wsj.com/articles/biogens-new-alzheimers-drug-meets-slow-rollout-11634733079?mod=pls_whats_news_us_business_f

Previous articleBear Bites Wisconsin Hunter After Breathing Down His Back 20 Feet up a Tree
Next articleMet Police chief says advice to women to ‘wave down a bus’ if arrested by a lone officer is nonsense